Methadone has the longest research history of any MAT medication for opioid use disorder. It must be dispensed through a federally licensed Opioid Treatment Program (OTP) — we coordinate the referral and treat the rest of your clinical picture in our continuum.
Kentucky Medicaid plans typically cover methadone treatment through participating OTPs, including the medication, daily dosing infrastructure, and required wraparound counseling.
Methadone for opioid use disorder is dispensed only through federally licensed Opioid Treatment Programs (OTPs) — a regulatory requirement set by SAMHSA and DEA. Induction is supervised on-site at the OTP and dose-titrated based on response.
Patients receive methadone daily at the OTP during the initial treatment phase. As clinical stability is established, take-home doses are gradually approved through SAMHSA's tiered schedule. Daily dosing transitions to weekly, then monthly take-homes over time.
Methadone has the longest research history of any MAT medication. Most patients remain on maintenance for years, and the clinical evidence consistently supports long-term treatment. Tapering, when clinically appropriate, is gradual and always planned with the prescribing clinician.
| Suboxone | Methadone | Vivitrol | |
|---|---|---|---|
| Mechanism | Partial agonist | Full agonist | Antagonist |
| Setting | Office-based | OTP only | Office-based |
| Frequency | Daily oral | Daily on-site | Monthly injection |
| Pre-treatment opioid-free | ~12–24 hrs | None required | 7–14 days |
| Overdose risk profile | Low (ceiling effect) | Moderate | None |
No. Methadone for opioid use disorder is dispensed only at federally licensed Opioid Treatment Programs (OTPs) — a federal regulatory requirement, not a Golden Grove decision. We coordinate with OTPs in the Louisville metro for patients who are clinically best matched to methadone, and we treat patients receiving methadone elsewhere within the rest of our clinical continuum.
Kentucky Medicaid plans typically cover methadone treatment through participating OTPs. Coverage includes the medication, the daily dosing infrastructure, and the wraparound counseling services OTPs are required to provide.
Federal regulation. Methadone for OUD has been governed by SAMHSA's OTP framework since the 1970s. Daily dosing supports clinical observation, dose calibration, and the wraparound counseling OTPs are required to provide. Stable patients earn take-home doses through a tiered schedule.
Methadone is a full opioid agonist — its respiratory-depressant effect scales with dose. Suboxone, as a partial agonist, has a ceiling effect that caps respiratory depression. Methadone's overdose risk is highest during induction, when doses are being titrated, and during the QTc-prolongation window for patients with cardiac risk factors.
Yes. Methadone has the strongest evidence base for long-tenure opioid use disorder, very high tolerance, and patients who have not responded to office-based MAT. The decision between Suboxone, Vivitrol, and methadone is clinical — we walk through the options with you on the call.
24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.